⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30547261 | 0.81 | — | — | |
| SCHEMBL29331921 | 0.81 | HTT (0.36) | — | |
| SCHEMBL4828045 | 0.81 | — | — | |
| SCHEMBL10184778 | 0.81 | — | — | |
| SCHEMBL1600771 | 0.79 | — | — | |
| SCHEMBL23461735 | 0.77 | — | — | |
| SCHEMBL2596826 | 0.77 | — | — | |
| SCHEMBL31125230 | 0.77 | — | — | |
| SCHEMBL17901852 | 0.77 | — | — | |
| SCHEMBL21246871 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102558041-A | Method for preparing 3,4-diamino-6-bromopyridine | HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | claimed |
| WO-2026102082-A1 | ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132119-A1 | Alkylphenyl Substituted Compounds, Compositions and Methods of Use | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4676926-A1 | BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS | ThirtyFiveBio Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| US-20250333399-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | KHORA SPV 1 LLC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12331039-B2 | Inhibitors of fibroblast growth factor receptor kinases | KHORA SPV 1, LLC (US) | 2025-06-17 | — | — | US | disclosed |
| EP-4559908-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | S2CBio Inc. (KR) | 2025-05-28 | — | — | EP | disclosed |
| WO-2025099451-A1 | NEW COMPOUNDS AND METHODS | Transition Bio Limited (GB) | 2025-05-15 | — | — | WO | disclosed |
| WO-2024184650-A1 | BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS. | ThirtyFiveBio Limited (GB) | 2024-09-12 | — | — | WO | disclosed |
| EP-3567041-B1 | SUBSTITUTED FUSED HETEROARYL COMPOUND SERVING AS A KINASE INHIBITOR, AND APPLICATIONS THEREOF | IMPACT THERAPEUTICS SHANGHAI INC (CN) | 2023-12-27 | — | — | EP | disclosed |
| WO-2013048214-A2 | NOVEL HETEROCYCLIC DERIVATIVES AND THEIR USES | C&C RESEARCH LABORATORIES (KR) | 2013-04-04 | — | — | WO | disclosed |
| CN-202376959-U | Liquid ammonia preparation device applied to production of 3,4-diamido-6-bromopyridine | HEFEI KESHANG MEDICAL TECHNOLOGY CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-202376959-U | Liquid ammonia preparation device applied to production of 3,4-diamido-6-bromopyridine | HEFEI KESHANG MEDICAL TECHNOLOGY CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-102558041-A | Method for preparing 3,4-diamino-6-bromopyridine | HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-102558041-A | Method for preparing 3,4-diamino-6-bromopyridine | HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-102558041-A | Method for preparing 3,4-diamino-6-bromopyridine | HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | disclosed |
| WO-2011149856-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| US-5795889-A | INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-08-18 | — | — | US | disclosed |
| US-5646153-A | INHIBITING ABNORMAL CELL PROLIFERATION | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-08 | — | — | US | disclosed |
| US-5480883-A | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-01-02 | — | — | US | disclosed |